- Sudden blindness possible rare side effect of popular diabetes & weight loss drugs WTVC
- GLP-1 drugs and vision loss: How significant are the risks? MedicalNewsToday
- Understanding the risk of diabetic retinopathy from glucagon-like peptide-1 receptor agonists: a Mendelian randomization study and systematic review of European populations Diabetology & Metabolic Syndrome
- Semaglutide, Tirzepatide Linked to Small Increase in Eye Disorder Risk AJMC
- 2 Minute Medicine Rewind August 18, 2025 2 Minute Medicine
Source link
